Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
- PMID: 28614178
- DOI: 10.1097/MLR.0000000000000738
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
Abstract
Background: The Centers for Disease Control and Prevention recognizes Medicaid as a high-risk population for fatal opioid overdose. Further research is needed to identify factors that put Medicaid patients at increased risk.
Objective: To determine whether patterns of opioid use are associated with risk of opioid-related mortality among opioid users.
Design: This is a retrospective cohort study.
Patients: In total, 150,821 noncancer pain patients aged 18-64 years with ≥1 opioid prescription, April 2006 to December 2010, Washington Medicaid.
Measures: Average daily dose (morphine equivalents), opioid schedule/duration of action, sedative-hypnotic use.
Results: Compared with patients at 1-19 mg/d, risk of opioid overdose death significantly increased at 50-89 mg/d [adjusted hazard ratio (aHR), 2.3; 95% confidence interval (CI), 1.4-4.1], 90-119 mg/d (aHR, 4.0; 95% CI, 2.2-7.3), 120-199 mg/d (aHR, 3.8; 95% CI, 2.1-6.9), and ≥200 mg/d (aHR, 4.9; 95% CI, 2.9-8.1). Patients using long-acting plus short-acting Schedule II opioids had 4.7 times the risk of opioid overdose death than non-Schedule II opioids alone (aHR, 4.7; 95% CI, 3.3-6.9). Sedative-hypnotic use compared with nonuse was associated with 6.4 times the risk of opioid overdose death (aHR, 6.4; 95% CI, 5.0-8.4). Risk was particularly high for opioids combined with benzodiazepines and skeletal muscle relaxants (aHR, 12.6; 95% CI, 8.9-17.9). Even at opioid doses 1-19 mg/d, patients using sedative-hypnotics concurrently had 5.6 times the risk than patients without sedative-hypnotics (aHR, 5.6; 95% CI, 1.6-19.3).
Conclusions: Our findings support Federal guideline-recommended dosing thresholds in opioid prescribing. Concurrent sedative-hypnotic use even at low opioid doses poses substantially greater risk of opioid overdose.
Similar articles
-
Association between opioid prescribing patterns and opioid overdose-related deaths.JAMA. 2011 Apr 6;305(13):1315-21. doi: 10.1001/jama.2011.370. JAMA. 2011. PMID: 21467284
-
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011-2015.J Gen Intern Med. 2018 Sep;33(9):1512-1519. doi: 10.1007/s11606-018-4532-5. Epub 2018 Jun 14. J Gen Intern Med. 2018. PMID: 29948815 Free PMC article.
-
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.JAMA. 2016 Jun 14;315(22):2415-23. doi: 10.1001/jama.2016.7789. JAMA. 2016. PMID: 27299617 Free PMC article.
-
Understanding Risk Factors for Opioid Overdose in Clinical Populations to Inform Treatment and Policy.J Addict Med. 2016 Nov/Dec;10(6):369-381. doi: 10.1097/ADM.0000000000000245. J Addict Med. 2016. PMID: 27525471 Review.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
Cited by
-
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial.Drug Alcohol Depend. 2024 Jun 1;259:111286. doi: 10.1016/j.drugalcdep.2024.111286. Epub 2024 Apr 5. Drug Alcohol Depend. 2024. PMID: 38626553 Clinical Trial.
-
New opioid prescription claims and their clinical indications: results from health administrative data in Quebec, Canada, over 14 years.BMJ Open. 2024 Apr 8;14(4):e077664. doi: 10.1136/bmjopen-2023-077664. BMJ Open. 2024. PMID: 38589264 Free PMC article.
-
Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations.Pain Med. 2024 Mar 1;25(3):173-186. doi: 10.1093/pm/pnad169. Pain Med. 2024. PMID: 38243702
-
Polysubstance use and post-discharge mortality risk among hospitalized patients with opioid use disorder.Prev Med Rep. 2023 Nov 4;36:102494. doi: 10.1016/j.pmedr.2023.102494. eCollection 2023 Dec. Prev Med Rep. 2023. PMID: 38116282 Free PMC article.
-
Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies.CMAJ. 2023 Oct 23;195(41):E1399-E1411. doi: 10.1503/cmaj.230459. CMAJ. 2023. PMID: 37871953 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous